In the present study, KRT19 was found overexpressed in breast, colon, lung, liver and thyroid cancer (Table 1), consistently with previous reports; KRT19 was associated with poor clinical outcomes in cancer patients as well (Kawai et al., 2015; Saha et al., 2019; Wang et al., 2019; Yuan et al., 2021). This evidence concerns the gene KRT19 and thyroid gland carcinoma.